• Publisher’s Note: Have IPF But Not Taking Meds? Take Our Survey.
  • Mortality Risk 37% Lower in IPF Patients on Ofev or Esbriet, Study Reports
  • CHMP Favors EU Approval of Ofev for Progressive Fibrosing ILDs
  • Blood Levels of Antioxidant Protein May Serve as IPF Biomarker
  • 6 People You Will Meet in an ICU Waiting Room
  • Stem Cells Derived from Amniotic Membrane Slow Lung Scarring in IPF Mouse Model
  • COVID-19 Delaying Rare Disease and Gene Therapy Trials, Pharma Execs Say
  • How I Manage My Energy Reserves with Pulmonary Fibrosis
  • Real-world Study Supports Effectiveness, Safety of Esbriet for Treating IPF
  • Ofev Approved in US and Canada for Progressive Fibrosing ILDs
  • Eurordis Urges Expansion of Newborn Screening Initiatives Across Europe
  • My Take on the Trach: It’s a Good Thing
  • In Certain IPF Patients with Lung Cancer, Ofev May Be Best Treatment